Roberto
N. Gonzales Jr. MD.
Edgardo Penserga,
M.D., FPCS, FPSGS
Reynaldo
Joson, M.D., MHA, MHPEd, MS Surg
Department of Surgery
Ospital ng
Maynila Medical
Center
Key words : granulomatous
mastitis
Reprint request : Roberto N. Gonzales Jr. M.D.
Department of Surgery, Ospital ng
Maynila Medical Center
OMMC Surgery@yahoogroups.com
Abstract
A 28 y/o female Filipino patient presented
with a 2 x 2 cm palpable mass on the upper outer quadrant of her left breast which
enlarged dramatically to 4 x 5 cm for the span of 3 weeks. Fine needle aspiration cytolology was
done and had been considered highly suspicious for carcinoma. Initial diagnosis was breast carcinoma and was planned to undergo
a modified radical mastectomy. But upon subsequent evaluation and work ups. The breast lesion was
confirmed to be a granulomatous mastitis hence planed MRM was withdrawn. Patient underwent 6 months
of anti koch’s medication and subsequently improved. Discussion
centered on Granulomatous Mastitis a very rare lesion of the brest which mimics breast carcinoma.
Introduction
Granulomatous lobular mastitis
is a rare disease primarily affecting young women, most often during pregnancy and/or lactation. This entity was first described
by Kessler and Wolloch in 1972 and further elaborated by Cohen in 1977.1 Approximately
55 cases have been described in the English literature, but many pathologists and clinicians are still unaware of the disease.
It is characterized by chronic, non-caseating granulomatous lobulitis
of unknown etiology. Failure to recognize granulomatous mastitis, which may be consequently mistaken
for breast carcinoma, has previously resulted in unnecessary mastectomies or open biopsies.
This is a case report of a female Filipino patient who was initially assessed to have breast carcinoma but on further
work-up was found to have a granulomatous mastitis.
This case report is made to develop the awareness on granulomatous mastitis
CASE REPORT
The patient, a 28-year-old woman, had been aware of a tender left breast
mass for 2 months. She had first consulted Ospital ng Maynila Medical
center surgery out patient department, where the results of fine needle aspiration cytology had been considered highly suspicious
for carcinoma. There was past history of tuberculosis, and chest x-ray was positive
for pulmonary tuberculosis. The patient was gravida 1, para 1. Her last
child had been delivered 2 years prior to admission, and had been breast-fed for 5 months.
Initial physical examination revealed a 2 x 2 cm2 hard mass in
the upper mid-lateral portion of the left breast. Axillary lymph nodes were not palpable. The tumor
enlarged rapidly and measured 4 x 5 cm2 within 3 weeks prior to admission. There was erythema
and crust like induration over the skin. Review of the initial aspirate
revealed clusters of atypical cells with large nuclei and a moderate N/C ratio. Slight nuclear hyperchromasia and small nucleoli were also seen. Since our clinical diagnosis was stage IIIA breast cancer,
the initial plan was to do modified radical masrectomy. However
upon further evaluation and review of slides for cytology. The inflammatory infiltrate included polymorphonuclear
leukocytes, plasma cells, epithelioid cells and Langhans-type giant cells
in the granuloma. There was evidence of tubercle formation
with caseous necrosis. (see figures 1 and 2). The axillary
lymph nodes were not pathologically affected by the granulomatous change. The final diagnosis was
idiopathic granulomatous mastitis, and the patient was informed that there was no malignant breast
disease. Patient underwent 6 months of anti koch’s medication and
subsequently improved.
DISCUSSION
Granulomatous mastitis is a rare, chronic, noncaseating,
granulomatous lobulitis of uncertain etiology. Clinically, it mimics breast
cancer and is frequently mistaken for a malignancy, particularly if the regional lymph nodes are enlarged.Thus,
failure to diagnose it may result in unnecessary mastectomies. The lesions of IGM are usually unilateral and can occur in any of the 4 quadrants.
The condition has been known to occur in both breasts. The clinical findings and mammographic results of IGM
are often similar to those of a carcinoma. As a result, a granulomatous reaction in a carcinoma
remains a critically important differential diagnosis for exclusion. However, most examples of this unusual complex have areas
composed of easily identified intraductal or invasive carcinoma. In rare cases, immunohistochemical
stains for cytokeratin or smooth muscle actin may be necessary to identify
a carcinoma against this background. Besides mimicking breast carcinoma, other diseases should also be excluded that might
cause a granuloma in the breast, such as tuberculosis, syphilis, and histoplasmosis
infections, as well as a foreign-body granuloma, vaccination granuloma,
mammary duct ectasia, sarcoidosis, Wegener’s
granulomatosis, giant cell arteritis, and polyarteritis
nodosa.
Histologically, IGM tissue is predominately composed
of inflammatory cells, mainly lymphocytes, associated with epithelioid histiocytes
admixed with Langhan’s giant cells. Stains for bacterial identification (such as acid-fast
stain, Gram stain, and Warthin-Starry stain) and those for fungal demonstration (for example, PAS
and GMS stains) are applied to rule out possible infectious granulomas. Bacterial culture, fungal
culture, and mycobacterial culture may be helpful but are much more time-consuming and relatively
expensive for exclusion of an infectious granuloma. Hence, the term IGM should be adopted for those
lesions which demonstrate no specific etiologic agent. Although its etiology is still unknown, several pathogeneses of granulomatous mastitis have been postulated including autoimmune( and infective processes(3)
and a local reaction to chemical secretions. Associations of IGM
with a recent pregnancy, breastfeeding, and oral contraceptives have been reported.
The
treatment of choice for IGM has not yet been established. Prior to 1980, because of the clinical impression of a possible
malignancy, surgical excision of the entire lesion was suggested. Complications seem to be related to both the disease process
and the surgical procedure and include skin ulceration, abscess formation, fistulae, wound infection, and recurrence. Some patients had relapses
in the form of chronic mastitis after excisional biopsies. Two decades ago, DeHertogh
suggested complete resection or open biopsy with 60 mg/kg/day prednisolone therapy for treatment
of granulomatous mastitis. Several other reports of using 60 mg/kg/day prednisolone
to treat IGM have also been published. With our patient, in view of her history of gestational diabetes, a conservative dosage of 30 m/day
prednisolone (0.6 mg/kg/day) was initiated with periodic blood sugar monitoring. However, her granulomatous mastitis recurred 11 weeks after the initial treatment. Prednisolone
at 40 mg/day (0.8 mg/kg/day) for 4 weeks was then administered with a successful result. Her blood sugar was controlled well
through her diet. Herein, we report a case of idiopathic granulomatous mastitis successfully treated
with 40 mg/day (0.8 mg/kg/day) prednisolone. As the administration of a steroid can cause some severe
adverse effects, such as opportunistic infections, dermatological manifestations, hypertension, peptic ulcer disease, neuropsychiatric symptoms, hyperglycemia, myopa thy, and osteoporosis, we feel
that the minimum dose of a steroid should be recommended. The duration and recommended dosage of steroid treatment deserve
further clinical research to establish an adequate treatment regimen.
References
:
1. Kessler E, Wolloch Y. Granulomatous mastitis: a
lesion clinically simulating carcinoma. Am J Clin Pathol 1972;58:642-6. MEDLINE Abstract
2. Cohen C. Granulomatous mastitis: a review of 5 cases. S Afr Med J 1977;52:14-6. MEDLINE Abstract
3. Brown LK, Tang PHL. Postlactational tumoral granulomatous
mastitis: a localized immune phenomenon. Am J Surg 1979;138:326-9.
4. DeHertogh DA, Rossof
AH, Harris AA, Economou SG. Prednisone management of granulomatous
mastitis. N Engl J Med 1980;308:799-800.
5. Carmalt HL, Ramsey-Stewart G. Granulomatous mastitis. Med
J Aust 1981;1:356-9. MEDLINE Abstract
6. Fletcher A, Magrath IM, Riddell RH, Talbot IC. Granulomatous
mastitis: a report of seven cases. J Clin Pathol 1982;35:941-5.
MEDLINE Abstract
7. Going JJ, Anderson TJ, Wilkinson S, Chetty U. Granulomatous
lobular mastitis. J Clin Pathol 1987;40:535-40.
MEDLINE Abstract
8. Banerjee A, Green B, Burke M. Tuberculous and granulomatous
mastitis. Practitioner 1989;233:754-7. MEDLINE Abstract
9. Osborne BM. Granulomatous mastitis caused by histoplasma
and mimicking inflammatory breast carcinoma. Hum Pathol 1982;20:38-42.
10. Macansh S, Greenberg M, Barraclough B, Pacey
F. Fine needle aspiration cytology of granulomatous mastitis:reports
of a case and review of the literature. Acta Cytol 1990;34:38-42. MEDLINE Abstract
11. Jorgensen MB,
Nielsen DM. Diagnosis and treatment of granulomatous mastitis. Am J Med 1992;93:97-101.
MEDLINE Abstract
12. Donn W, Rebbeck P, Wilson C, Gilks
CB. Idiopathic granulomatous mastitis: a report of three cases and review of the literature. Arch
Pathol Lab Med 1994;118:822-5. MEDLINE Abstract